Loading organizations...
§ Private Profile · San Francisco, CA, USA
Plenful is a technology company.
Plenful delivers an AI-powered platform automating manual, administrative workflows specifically within healthcare operations. Its technology streamlines processes for pharmacies and healthcare entities, leveraging artificial intelligence to enhance efficiency and reduce operational friction through a flexible, no-code approach.
The company was founded in 2021 by CEO Joy Liu. Plenful emerged from the critical insight into prevalent operational inefficiencies within the healthcare sector, particularly in pharmacy settings. Liu’s professional background and direct experience in healthcare informed this recognition, driving the creation of a tailored solution for these bottlenecks.
Plenful's platform serves pharmacy leaders and healthcare operations teams, aiming to significantly reduce administrative burdens and optimize workflows. The company's vision is to advance the healthcare industry through intelligent automation, ultimately enabling professionals to dedicate more time to direct patient care by alleviating repetitive task loads.
Plenful has raised $85.0M across 4 funding rounds.
Plenful has raised $85.0M in total across 4 funding rounds.
Plenful has raised $85.0M in total across 4 funding rounds.
Plenful's investors include Mitchell Rales, Arena Holdings, Bessemer Venture Partners, First Row Partners, Chelcie Taylor, Notable Capital, Preston-Werner Ventures, TQ Ventures, Trajectory Ventures, Rohini Pandhi, Susa/Kivu Ventures, Susa Ventures.
Plenful has raised $85.0M across 4 funding rounds. Most recently, it raised $50.0M Series B in April 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2025 | $50M Series B | Mitchell Rales, Arena Holdings | Bessemer Venture Partners, First ROW Partners, Chelcie Taylor, Notable Capital, Preston Werner Ventures, TQ Ventures, Trajectory Ventures, Rohini Pandhi, Susa/Kivu Ventures | Announced |
| May 1, 2024 | $17M Series A | TQ Ventures | First ROW Partners, Preston Werner Ventures, Trajectory Ventures, Rohini Pandhi, Mitchell Rales, Bessemer Venture Partners, Susa Ventures | Announced |
| Oct 10, 2023 | $9M Venture Round | Andrew Hedin | — | Announced |
| Oct 1, 2023 | $9M Seed | Bessemer Venture Partners | Chelcie Taylor, TQ Ventures | Announced |
Plenful is an AI-powered workflow automation platform designed for pharmacy and healthcare operations, automating administrative tasks like 340B compliance auditing, inventory management, document processing, rebate management, and prior authorizations.[1][2][5] It serves health systems, pharmacies (including specialty, long-term care, compounding, and manufacturers), and provider groups, solving labor-intensive manual processes that cause inefficiencies, errors, high costs, and staff burnout by streamlining unstructured data handling and enabling focus on patient care.[1][2][4][5] With over 20 enterprise customers like Tampa General Hospital, Renown Health, and Mercy Med, Plenful has raised $9 million in funding and demonstrates strong growth through rapid adoption and investor backing from Bessemer Venture Partners, TQ Ventures, Susa Ventures, and others.[3][4]
Plenful was founded in 2021 in San Francisco by experienced pharmacy operators, including CEO Joy Liu, who identified inefficiencies while working at health systems and specialty pharmacies like Shields Health Solutions.[1][2][4] The idea emerged from firsthand exposure to labor shortages, rising administrative burdens, and manual tasks in pharmacy operations, prompting the team to build a no-code AI platform for workflow automation.[2][4] Early traction came quickly, with more than 20 health systems and pharmacy customers adopting the platform shortly after launch, alongside a $9 million funding round led by Bessemer Venture Partners in 2023.[4]
Plenful rides the wave of AI-driven healthcare automation, addressing acute labor shortages, clinician burnout, and rising operational costs amid growing medication volumes and regulatory demands like 340B compliance.[2][4][5] Its timing aligns with post-pandemic pressures on pharmacies and health systems, where manual administrative tasks divert resources from patient care, amplified by unstructured data challenges that generic AI struggles with.[1][4] Market forces favoring Plenful include explosive demand for scalable, sector-specific automation—evident in its rapid customer wins and investor interest from healthcare-focused VCs—positioning it to influence the ecosystem by enabling "top-of-license" work, optimizing revenue, and setting standards for compliant, efficient pharmacy operations.[3][4]
Plenful is poised for accelerated expansion by deepening penetration in 340B optimization, prior authorizations, and rebate workflows, potentially capturing more of the $100B+ U.S. pharmacy operations market as AI maturity grows.[1][5] Trends like advancing multimodal AI for healthcare data, regulatory pushes for efficiency, and staffing constraints will propel its growth, with opportunities to expand into adjacent areas like full revenue cycle automation. Its operator roots and configurability could evolve it into a category leader, empowering more organizations to reallocate staff to care delivery while sustaining momentum through strategic partnerships and further funding. This positions Plenful as a key enabler in taming healthcare's administrative chaos, directly advancing its founding mission.[2][4]